137 completed, 33 unknown, 23 recruiting, 20 terminated. 123 Not applicable, 28 Phase 4, 26 Phase 3, 19 Phase 2, 7 Phase 1.
Follow Urinary Incontinence, Urge: new trials by email Literature Review of Urinary Incontinence, Urge trials Research Report on Urinary Incontinence, Urge
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment Efficacy for Overactive Bladder: Comparing Education, Biofeedback, and Nerve Stimulation Behavioral, Enraf-Nonius EMG-Biofeedback Unit (Biofeedback only), Enraf-Nonius EMG-Biofeedback Unit (Biofeedback + Electrical Stimulation) - Urinary Bladder, Overactive, Urinary Incontinence, Urge | Not applicable | Not yet recruiting | Far Eastern Memorial Hospital | 201 | 2026-08-03 | 2026-08-04 |
| Pelvic Floor Rehabilitation Programme for Women With Urinary Incontinence in a Peruvian Public Hospital Supervised group pelvic floor muscle training, Individual physiatrist-led pelvic floor sessions - Urinary Incontinence, Urinary Incontinence, Stress | Not applicable | Active not recruiting | Hospital Nacional Edgardo Rebagliati Martins | 89 | 2026-08-03 | 2026-10-05 |
| Urinary Continence After Vaginal Surgery for Genital Prolapse in the Spanish Population. Vaginal surgery for pelvic organ prolapse - Pelvic Organ Prolapse (POP), Pelvic Organ Prolapse Vaginal Surgery | Not yet recruiting | Hospital Universitari Vall d'Hebron Research Institute | 1042 | 2026-08-01 | 2026-06-04 | |
| Fluoroscopy Radiation Reduction During Sacral Neuromodulation Lead Placement Reduced radiation fluoroscopy, Conventional fluoroscopy - Radiation Exposure, Overactive Bladder | Not applicable | Recruiting | Loma Linda University | 44 | 2026-06-01 | 2026-03-06 |
| Aquarius Pilot Study to Evaluate the New Axonics Trial System Axonics External Trial System (ETS) - Urinary Urge Incontinence (UUI), Urinary Frequency (UF) | Not applicable | Recruiting | Axonics, Inc. | 75 | 2026-04-30 | 2026-10-13 |
| Vitamin D Treat-to-Target Strategy for Children With Overactive Bladder-Wet urotherapy, Solifenacin Succinate, Vitamin D3 - Urinary Bladder, Overactive, Overactive Bladder | Not applicable | Recruiting | Children's Hospital of Chongqing Medical University | 180 | 2026-04-20 | 2026-04-17 |
| COMPARATIVE EFFICACY OF ELECTROMAGNETIC FIELD THERAPY AND TIBIAL NERVE STIMULATION IN URGE URINARY INCONTINENCE Magnetic Field Therapy (PEMF), Posterior Tibial Nerve Stimulation (PTNS), Pelvic Floor Muscle Exercise Program - Urge Urinary Incontinence | Not applicable | Not yet recruiting | Kanuni Sultan Suleyman Training and Research Hospital | 40 | 2026-04-01 | 2026-04-17 |
| Neuspera Revision Registry - Follow up Revision Experience and Evaluation of Device Outcomes Metrics Neuspera Implantable Sacral Neuromodulation System - Urinary Urge Incontinence | Recruiting | Neuspera Medical, Inc. | 100 | 2026-04-01 | 2026-10-14 | |
| Post Approval Effectiveness and Durability Evaluation of the Altaviva™ Tibial Device Altaviva™ system - Urge Urinary Incontinence | Not applicable | Recruiting | MedtronicNeuro | 256 | 2026-03-17 | 2026-10-20 |
| Long-term Outcomes of Urethral and Uterosacral Ligament Plication uterosacral ligament plication, urethral ligament plication - Incontinence Stress, Incontinence, Urge | Not applicable | Completed | Alev Esercan | 200 | 2026-02-01 | 2026-09-09 |
| A Randomized, Placebo-controlled Trial of Nitrous Oxide During In-office Bladder Botox Injections Pro-Nox Nitrous Oxide/Oxygen Delivery System, Standard Care for Bladder Botox Injection, Sham Mask - Overactive Bladder, Neurogenic Bladder | Phase 4 | Not yet recruiting | TriHealth Inc. | 96 | 2026-02-01 | 2026-02-04 |
| Telerehabilitation Versus Supervised Pelvic Floor Muscle Training in Urinary Incontinence Telerehabilitation Pelvic Floor Muscle Training (TR-PFMT) Group, Supervised Pelvic Floor Muscle Training (S-PFMT) Group - Urinary Incontinence, Urinary Incontinence,Stress | Not applicable | Completed | Riphah International University | 54 | 2026-02-01 | 2026-08-26 |
| Efficacy and Safety of 7 Millimeters Vaginal Radiofrequency in Overactive Bladder Radiofrequency - Overactive Bladder (OAB), Incontinence, Urge | Not applicable | Not yet recruiting | IRCCS San Raffaele | 48 | 2025-12-16 | 2025-12-12 |
| Detrusor Nerve Radiofrequency Ablation for Overactive Bladder in Women Detrusor nerve radiofrequency ablation, Simulated (sham) detrusor nerve radiofrequency ablation - Overactive Bladder, Overactive Bladder (OAB) | Not applicable | Recruiting | InMode MD Ltd. | 202 | 2025-11-25 | 2026-01-30 |
| Study of 30-Minute Stimulation With the Neuspera Sacral Neuromodulation (SNM) System Neuspera Implantable Sacral Neuromodulation System - Urinary Urge Incontinence | Not applicable | Recruiting | Neuspera Medical, Inc. | 30 | 2025-11-19 | 2026-03-05 |
| Low-intensity Shockwave Therapy Versus Solifenacin for the Treatment of Overactive Bladder in Women Low intensity shockwave therapy, Oral Solifenacin succinate 5 mg - Overactive Bladder (OAB), Urge Incontinence | Phase 4 | Recruiting | Mansoura University | 70 | 2025-11-11 | 2026-03-16 |
| Pelvic Floor Disorder Symptoms in Women Seeking Weight Loss Therapy Bariatric Surgery, GLP1 receptor agonist - Lower Urinary Tract Symptoms, Stress Urinary Incontinence | Not yet recruiting | Hartford HealthCare | 200 | 2025-10-01 | 2025-09-16 | |
| High Intensity Magnetic Stimulation on Urge Urinary Incontinence in Postmenopausal Women Pelvic floor muscle training + Pelvic magnetic stimulation, Pelvic floor muscle training - High Intensity Magnetic Stimulation, Urge Urinary Incontinence | Not applicable | Completed | Kafrelsheikh University | 50 | 2025-09-21 | 2026-07-28 |
| PMCF Study of the Axonics SNM System Model 5101 (R20) for the Indication of OAB Axonics SNM System INS Model 5101 (R20) - Urinary Urge Incontinence (UUI), Urinary Frequency (UF) | Not applicable | Recruiting | Axonics, Inc. | 55 | 2025-09-18 | 2026-10-13 |
| Assessing the Genitourinary Microbiome of Women With Overactive Bladder Undergoing Onabotulinum Toxin Type A Intradetrusor Injections onabotulinum toxin type a - Overactive Bladder (OAB), Urge Incontinence | Recruiting | Alexis Dieter | 40 | 2025-09-03 | 2025-09-12 |
Showing 20 of 241. Sign in to see all of them.
Urinary Bladder, Overactive (131) · Urinary Incontinence (75) · Urinary Incontinence, Stress (49) · Nocturia (16) · Lower Urinary Tract Symptoms (15) · Fecal Incontinence (12) · Urinary Bladder, Neurogenic (10) · Pelvic Organ Prolapse (9) · Nocturnal Enuresis (6) · Pelvic Floor Disorders (5) · Urologic Diseases (5) · Multiple Sclerosis (4) · Urinary Retention (4) · Female Urogenital Diseases (3)
Male Urogenital Diseases (241) · Pathological Conditions, Signs and Symptoms (241) · Signs and Symptoms (241) · Urogenital Diseases (241) · Female Urogenital Diseases and Pregnancy Complications (240) · Urination Disorders (240) · Urological Manifestations (240) · Female Urogenital Diseases (238) · Urologic Diseases (236) · Lower Urinary Tract Symptoms (226) · Urinary Incontinence (166) · Urinary Bladder Diseases (131) · Nervous System Diseases (16) · Neurologic Manifestations (15) · Digestive System Diseases (14)
Tolterodine Tartrate (21) · Botulinum Toxins, Type A (13) · Solifenacin Succinate (13) · mirabegron (11) · oxybutynin (6) · Transcutaneous Electric Nerve Stimulation (5) · fesoterodine (5) · Lidocaine (4) · N-(4-((5-(hydroxy(phenyl)methyl)pyrrolidin-2-yl)methyl)phenyl)-4-oxo-4,6,7,8-tetrahydropyrrolo(1,2-a)pyrimidine-6-carboxamide (3) · Suburethral Slings (3) · ritobegron ethyl (3) · Biofeedback, Psychology (2) · Electric Stimulation (2) · Mindfulness-Based Stress Reduction (2) · Phenazopyridine (2)
Astellas Pharma Inc (6) · Axonics, Inc. (6) · MedtronicNeuro (6) · University of California, San Francisco (6) · InnoCon Medical (4) · NICHD Pelvic Floor Disorders Network (4) · University of New Mexico (4) · Urovant Sciences GmbH (4) · Valencia Technologies Corporation (4) · Amber Therapeutics Ltd (3) · Avation Medical, Inc. (3) · Kissei Pharmaceutical Co., Ltd. (3) · Laborie Medical Technologies Inc. (3) · Loma Linda University (3) · Loyola University (3)
United States (135) · United Kingdom (15) · Netherlands (13) · Turkey (Türkiye) (12) · Belgium (11) · Canada (11) · Denmark (11) · Spain (11) · Germany (9) · Egypt (8) · France (8) · China (6) · Italy (6) · Czechia (5) · Israel (5)
Karen Noblett, MD (3) · Yasuhiro Omori (3) · Becky Clarkson, PhD (2) · Felicia Lane, MD (2) · Gita Ghadimi, OD (2) · Ilan Gruenwald, MD (2) · Kenneth Peters, MD (2) · Peter Christensen, MD (2) · Rose Khavari, MD (2) · Scott MacDiarmid, MD (2) · Wolfram H Jager, PhD (2)
PMID 37160401, PMID 37811598, PMID 24246044, PMID 33620895, PMID 39704322, PMID 10767443, PMID 14662404, PMID 17803192, PMID 17905093, PMID 18499184, PMID 19233423, PMID 19302497, PMID 19941278, PMID 20639023, PMID 21420124, PMID 21458914, PMID 22008247, PMID 22036776, PMID 22151641, PMID 22741748, PMID 23036134, PMID 23168606, PMID 23218404, PMID 23370938, PMID 23424164, PMID 23460503, PMID 24091564, PMID 24176946, PMID 24486637, PMID 24519688, PMID 24972732, PMID 25022469, PMID 25165780, PMID 25238744, PMID 25682782, PMID 25937539, PMID 26068624, PMID 26314640, PMID 26451967, PMID 26516810, PMID 27321890, PMID 27564385, PMID 27794195, PMID 28914707, PMID 29031894, PMID 29324595, PMID 29398096, PMID 30193294, PMID 31059663, PMID 31211964
2017 (2), U01HD069031 (2), U10HD041261 (2), U10HD041267 (2), U10HD054214 (2), U10HD054215 (2), R01AG020629 (1), R01AG043383 (1), R01AG075471 (1), R01AT007171 (1), R01DK116712 (1), R01NR012011 (1), R03AG038583 (1), R03AG042335 (1), R21AG064361 (1)